Application 210875

Type: NDA
Sponsor: SUNOVION PHARMS INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	KYNMOBI	APOMORPHINE HYDROCHLORIDE	FILM;SUBLINGUAL	10MG	Yes	No
002	KYNMOBI	APOMORPHINE HYDROCHLORIDE	FILM;SUBLINGUAL	15MG	Yes	No
003	KYNMOBI	APOMORPHINE HYDROCHLORIDE	FILM;SUBLINGUAL	20MG	Yes	No
004	KYNMOBI	APOMORPHINE HYDROCHLORIDE	FILM;SUBLINGUAL	25MG	Yes	No
005	KYNMOBI	APOMORPHINE HYDROCHLORIDE	FILM;SUBLINGUAL	30MG	Yes	No

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-010	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-015	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-020	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-025	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-030	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-088	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-110	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-115	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-120	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-125	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-130	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current
63402-188	KYNMOBI	apomorphine hydrochloride	Sunovion Pharmaceuticals Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
72149	SUPPL	2022-09-23
72144	SUPPL	2022-09-23
71022	SUPPL	2022-05-06
71007	SUPPL	2022-05-06
64831	ORIG	2020-10-06
63317	ORIG	2020-05-28
63250	ORIG	2020-05-21

Application 210875

Related Records#

Application Products#

NDC Listings For This Application#

Documents#